Company intelligence / Profile preview

Epidarex Capital

Bethesda, Maryland, United Statesepidarex.com ↗

Ownership: Private
Employees: ~15
Development stage: Other

Overview

Epidarex Capital does not conduct clinical trials itself but invests in early-stage life science and health technology startups developing innovative therapeutics, devices, diagnostics, and platforms. Its portfolio includes several clinical-stage biotech and medtech firms with programs spanning from preclinical to Phase 3.

Industry: Investors

Partnerships

Partners with research institutions/universities as co-investors or spin-out founders.Portfolio partnerships include major pharma collaborations via investee companies.

Beyond the preview

Go deeper on Epidarex Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Epidarex Capital.

Explore the full profile